Literature DB >> 16316691

Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.

Olivier Gach1, Monique Nys, Ginette Deby-Dupont, Jean-Paul Chapelle, Maurice Lamy, Luc A Piérard, Victor Legrand.   

Abstract

BACKGROUND: Polymorphonuclear neutrophils have been implicated in the pathophysiology of atherosclerosis. A substantial body of evidence has emerged to implicate the role of specific leucocyte derived enzyme myeloperoxidase in atherogenesis, since its initiation through progression until destabilization. The aim of the study was to determine the presence of polymorphonuclear neutrophils activation after coronary stenting, to compare this activation between stable and unstable setting and to evaluate the kinetic relation of this activation with inflammatory response following atherosclerotic plaque rupture.
METHODS: Myeloperoxidase, lactoferrin, elastase, C-reactive protein and cytokine plasma levels were assessed in 15 patients undergoing direct coronary stenting for unstable angina (Group A) and compared to 11 patients undergoing this procedure for stable angina (Group B). Serial sampling starting before arteriography and continued for 24 h was carried out in all patients.
RESULTS: A significant elevation in myeloperoxidase and lactoferrin levels was observed after stenting in both group A (p<0.0001) and group B (p<0.0001), but was higher in group A. Interleukin-8, interleukin-12 and interleukin-6 levels increased temporarily after stenting in the 2 groups. Baseline values of C-reactive protein were similar in the 2 groups and a progressive increase was observed after the intervention.
CONCLUSIONS: Direct coronary artery stenting is associated with an early polymorphonuclear neutrophils activation followed by release of inflammatory cytokines (interleukin-6, interleukin-8, interleukin-12) and C-reactive protein elevation in both stable and unstable patients. We conclude that stenting by itself is associated with myeloperoxidase liberation with a significantly enhanced response in unstable patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316691     DOI: 10.1016/j.ijcard.2005.09.010

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Effect of various doses of rosuvastatin in the treatment of elderly patients with unstable angina pectoris.

Authors:  Jingyun Fang; Xueli Zhang
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

2.  Suppression of superoxide anion and elastase release by C18 unsaturated fatty acids in human neutrophils.

Authors:  Tsong-Long Hwang; Yi-Chia Su; Han-Lin Chang; Yann-Lii Leu; Pei-Jen Chung; Liang-Mou Kuo; Yi-Ju Chang
Journal:  J Lipid Res       Date:  2009-03-17       Impact factor: 5.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.